Snow Disease Surveillance System Study

This study is enrolling participants by invitation only.
Sponsor:
Collaborators:
University of Tromso
The Royal Norwegian Ministry of Health
Norwegian Health Network (state owned enterprise)
Information provided by (Responsible Party):
University Hospital of North Norway
ClinicalTrials.gov Identifier:
NCT01232686
First received: October 15, 2010
Last updated: November 2, 2011
Last verified: November 2011
  Purpose

The study investigates whether shared online access to epidemiological data for general practitioners, disease prevention officers, emergency care services and microbiology laboratories changes clinical practice with regard to testing, diagnosing and treatment of communicable diseases. The main hypothesis is that "online access for general practitioner to epidemiological data about communicable diseases changes clinical practice for testing, diagnosing and treatment of communicable diseases".


Condition Intervention
Communicable Diseases
Other: Online disease surveillance data access

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Snow Disease Surveillance System Study

Resource links provided by NLM:


Further study details as provided by University Hospital of North Norway:

Primary Outcome Measures:
  • Earlier diagnosis and treatment for communicable diseases [ Time Frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012) ] [ Designated as safety issue: No ]

    General practitioners (GP) have three possible decisions in a consultation with a patient; 1) treat on suspicion, 2) take a sample, 3) wait and see whether the patient recovers or get worse, or 4) a combination of 1 and 2.

    In situations with decision 3 (wait and see) the patient may return to a consultation later on.

    The hypothesis is that online access to epidemiological data from the local patient population will enable GPs to make the right decision more often based on knowledge about the epidemiological situation in the patient population.



Secondary Outcome Measures:
  • Earlier detection of local disease outbreaks [ Time Frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012) ] [ Designated as safety issue: No ]
    Syndromic surveillance enables earlier detection of local disease outbreaks compared to traditional laboratory based surveillance. We will record the time of disease outbreak detection in both intervention and control areas and compare.

  • Lower number of infected during disease outbreaks [ Time Frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012) ] [ Designated as safety issue: No ]
    We will compare the number of infected in the intervention and control areas. The hypothesis is that the intervention areas will have fewer infected compared to the control areas.

  • Impact on health service costs [ Time Frame: Measured at the end of the data collection period, approx. 1.5 year. (December 2012) ] [ Designated as safety issue: No ]
    We will measure the cost related to communicable diseases in the control and intervention areas. Our prediction is that it will change.


Estimated Enrollment: 200
Study Start Date: October 2010
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: Control area
In the control areas we will monitor the prevalence and treatment of communicable diseases without giving the participants online access to disease surveillance information
Experimental: Intervention area
In these areas we will give study participants online access to epidemiological data for communicable diseases
Other: Online disease surveillance data access
In the intervention areas we will give the study participants online access to the Snow disease surveillance system. The system will provide data about the incidents of respiratory and gastrointestinal communicable diseases in the patient population.

Detailed Description:

We will collect data from general practitioners (GP) offices by installing local data extraction solutions. Each installation will build a local anonymous database of GP consultations extracted from the local electronic patient record (EPR) system. These anonymous data records will be used to produce local disease statistics before they are exported to a centralized server available in the Norwegian Health network. The centralized server will produce daily reports about the epidemiological situation in the patient population. We will combine the syndromic data from the GP offices with data from the microbiology laboratories on the hospitals that covers the study areas. The epidemiological data will be made available to the intervention areas in the study through web based and customized client applications.

By using data extracted from the GP offices EPR databases and the microbiology laboratories we will investigate the study hypothesis.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Volunteering General Practitioner (GP) working in a GP office

Exclusion Criteria:

  • The GP does not use a Electronic Patient Record (EPR) system
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01232686

Sponsors and Collaborators
University Hospital of North Norway
University of Tromso
The Royal Norwegian Ministry of Health
Norwegian Health Network (state owned enterprise)
Investigators
Principal Investigator: Johan Gustav Bellika, PhD University of Tromsø, Department of Computer Science
  More Information

No publications provided

Responsible Party: University Hospital of North Norway
ClinicalTrials.gov Identifier: NCT01232686     History of Changes
Other Study ID Numbers: ID 3746/ HST954-10
Study First Received: October 15, 2010
Last Updated: November 2, 2011
Health Authority: Norway: Data Protection Authority
Norway: Directorate of Health

Keywords provided by University Hospital of North Norway:
Communicable Diseases
Epidemiology
Population surveillance
Computerized Medical Record
Data collection

Additional relevant MeSH terms:
Communicable Diseases
Infection

ClinicalTrials.gov processed this record on July 22, 2014